Connect with us

archive

S&P 500 Rises on Pharmaceutical Deal Despite Disappointing Data

S&P 500 Rises Despite Disappointing Data (Bloomberg)

New York-area manufacturing data did not live up to forecasts, but a $25 billion deal by pharmaceutical company Actavis Plc to buy Forest Laboratories buoyed the market. The S&P 500 rose 0.1%, to within eight points of its record close. “Weaker economic numbers have been shrugged off,” Eric Green, director of research and fund manager at Philadelphia-based Penn Capital Management, said. “It seems like the consensus view is that weather is a huge issue in the numbers. The outlook looks pretty benign right now. We can probably reach new highs in the near term in the equity markets.”

Newsletter Signup.

Sign up to the Human Events newsletter

Advertisement
Advertisement

TRENDING NOW:

Buzzfeed Bashes 14-Yr-Old Trump Fan, Celebrates Kids in Drag.

TECH

‘Reaganesque’: Economist Tells CNBC Trump Could Shift Global Order In China Trade War

FOREIGN AFFAIRS

Al Jazeera: ‘Jews Exploit Holocaust’.

FOREIGN AFFAIRS

Dunkin Donuts Refuses to Get Woke: ‘We Are Not Starbucks’

CULTURE

New York-area manufacturing data did not live up to forecasts, but a $25 billion deal by pharmaceutical company Actavis Plc to buy Forest Laboratories buoyed the market.

archive

S&P 500 Rises on Pharmaceutical Deal Despite Disappointing Data

New York-area manufacturing data did not live up to forecasts, but a $25 billion deal by pharmaceutical company Actavis Plc to buy Forest Laboratories buoyed the market.

S&P 500 Rises Despite Disappointing Data (Bloomberg)

New York-area manufacturing data did not live up to forecasts, but a $25 billion deal by pharmaceutical company Actavis Plc to buy Forest Laboratories buoyed the market. The S&P 500 rose 0.1%, to within eight points of its record close. ??Weaker economic numbers have been shrugged off,? Eric Green, director of research and fund manager at Philadelphia-based Penn Capital Management, said. ??It seems like the consensus view is that weather is a huge issue in the numbers. The outlook looks pretty benign right now. We can probably reach new highs in the near term in the equity markets.?

Newsletter Signup.

Sign up to the Human Events newsletter

Written By

TRENDING NOW:

Buzzfeed Bashes 14-Yr-Old Trump Fan, Celebrates Kids in Drag.

TECH

‘Reaganesque’: Economist Tells CNBC Trump Could Shift Global Order In China Trade War

FOREIGN AFFAIRS

Al Jazeera: ‘Jews Exploit Holocaust’.

FOREIGN AFFAIRS

Dunkin Donuts Refuses to Get Woke: ‘We Are Not Starbucks’

CULTURE

Connect
Newsletter Signup.

Sign up to the Human Events newsletter